Keyphrases
COVID-19
100%
Clinical Outcomes
100%
Mechanically Ventilated
100%
Tocilizumab
100%
Clinical Improvement
44%
Mechanically Ventilated Patients
22%
Houston
11%
United States
11%
Texas
11%
Management Strategy
11%
Treatment Strategy
11%
Monoclonal Antibody
11%
Hospital Systems
11%
Mortality Rate
11%
Randomized Controlled Trial
11%
Adverse Reactions
11%
Multivariable
11%
Effective Treatment
11%
Respiratory Distress
11%
Cytokine Release
11%
Severe Disease
11%
Repeated Administration
11%
Critically Ill Patients
11%
Extubation
11%
Potential Treatments
11%
Critically Ill
11%
Transaminitis
11%
Interleukin-6 Receptor (IL-6R)
11%
Retrospective Cohort Analysis
11%
Weight-based Dose
11%
Flat Dose
11%
Cytokine Release Syndrome
11%
Invasive Mechanical Ventilation
11%
Severe Coronavirus Disease 2019
11%
Mortality Improvement
11%
Medicine and Dentistry
Tocilizumab
100%
COVID-19
100%
Diseases
11%
Randomized Controlled Trial
11%
Adverse Event
11%
Monoclonal Antibody
11%
Mortality Rate
11%
Artificial Respiration
11%
Respiratory Distress
11%
Cohort Analysis
11%
Extubation
11%
Cytokine Release
11%
Interleukin 6 Receptor
11%
Elevated Transaminase
11%
Cytokine Release Syndrome
11%